Lipid metabolism, adipokine signaling, and nutrient absorption pathways

Lipid metabolism, adipokine signaling, and nutrient absorption pathways represent a complex, integrated network of physiological processes essential for maintaining systemic energy homeostasis. Lipid metabolism involves the highly regulated synthesis, transport, and degradation of fats, primarily managed by enzymes such as HMG-CoA reductase and various lipoprotein lipases (StatPearls, 2023). Adipokine signaling refers to the endocrine function of adipose tissue, which secretes hormones like leptin and adiponectin to communicate energy status to the central nervous system and peripheral tissues, thereby influencing insulin sensitivity and appetite (NIH, 2022). Nutrient absorption pathways facilitate the uptake of dietary lipids, carbohydrates, and proteins in the gastrointestinal tract, utilizing specialized transporters like NPC1L1 for cholesterol (PubMed, 2021). Chronic dysregulation of these pathways is a primary driver of metabolic syndrome, contributing to the development of obesity, type 2 diabetes, and cardiovascular disease (Nature Reviews Endocrinology, 2020). While this entry describes a broad set of biological processes rather than a single molecular target, it contains numerous validated therapeutic targets that are modulated by drugs such as statins, GLP-1 receptor agonists, and ezetimibe to manage metabolic health.

Other names

Metabolic pathwaysEnergy homeostasis networkLipid and endocrine signalingMetabolic syndrome pathways

Therapeutic agents modulate these pathways through diverse mechanisms, including the inhibition of cholesterol synthesis (HMG-CoA reductase inhibitors), activation of nuclear receptors (PPAR-alpha/gamma agonists), enhancement of incretin signaling (GLP-1 receptor agonists), and inhibition of dietary fat absorption (gastric and pancreatic lipase inhibitors).